NASDAQ | TSX: ACB European grant advances Aurora's unparalleled leadership in cannabis genetics, enhancing its position as a leading medical cannabis company EDMONTON, AB, Jan. 20, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, today announces that it has been granted community plant variety rights by the EU's Community Plant Variety Office for two of its proprietary cannabis varieties. This achievement further strengthens the c ...

Key Points Tilray's latest financial results were fairly strong. The company could have a large market opportunity in the U.S. However, Tilray still faces significant challenges. 10 stocks we like better than Tilray Brands › Is Tilray Brands (NASDAQ: TLRY) finally turning things around? After terrible performances during the past five years -- when the business lost more than 90% of its market value -- the company has had strong momentum in the past six months. Much of that was due to positive r ...

Core Insights - The article highlights Alan Brochstein's extensive experience in the investment industry, particularly his focus on the cannabis sector since 2014 [1] - It emphasizes the importance of ETFs in enabling diversified investment portfolios for both individual and institutional investors [1] - The article mentions Brochstein's efforts to educate investors about the ETF landscape and the associated risks [1] Group 1: Professional Background - Alan Brochstein has been contributing to Seeking Alpha since 2007 and has a background in both sell-side and buy-side roles in fixed-income and equities [1] - He founded AB Analytical Services in 2007 to provide independent consulting to registered investment advisors [1] - Brochstein launched 420 Investor in 2013, focusing on cannabis stocks, and has been a significant figure in the cannabis investment space since then [1] Group 2: ETF Focus - Brochstein has been writing extensively about ETFs since 2025, aiming to help investors understand the ETF universe [1] - He maintains a 79-ETF Focus List that includes both popular and lesser-known ETFs that he believes stand out [1] - A model portfolio was created by Brochstein as of year-end 2025 to assist investors in navigating their ETF investments [1]

President Donald Trump's recent executive order urging the Department of Justice to reschedule cannabis to Schedule 3 is being hailed as the "most consequential federal cannabis policy shift" in over 50 years.Dan Ahrens, portfolio manager of the AdvisorShares Pure US Cannabis ETF (NYSE:MSOS) , says the move could finally dismantle the crippling tax regime that has stifled American cannabis operators for decades.The End Of ‘Narcotics Trafficker’ StatusAhrens told Yahoo Finance that the immediate financial ca ...

Core Insights - Simply Solventless Concentrates Ltd. (SSC) is enhancing its cultivation facility through a retrofit by its subsidiary Humble Grow Co., which is expected to significantly increase revenue and EBITDA [2][6]. Humble Retrofit - The retrofit involves the installation of LED lights and other improvements, with a total capital cost of approximately $2.5 million, netting to $1.5 million after government rebates [2]. - Once the retrofit is fully operational by early Q3 2026, SSC anticipates an increase in annual gross revenue by $17.5 million to $29.5 million, resulting in total revenue projections of $53.5 million to $65.5 million [2][3]. - The adjusted EBITDA is expected to rise by $6.5 million to $14.5 million, reaching a range of $10.7 million to $18.7 million [2][5]. Market Expansion - SSC plans to maintain a balanced sales mix of 50% B2B and 50% CPG (consumer packaged goods) post-retrofit, targeting both domestic and international markets [3][7]. - The company has set pricing for saleable cannabis flower at $3.00 per gram for CPG, $1.60 for Canadian B2B, and $1.90 for international B2B [7]. Acquisition Integration & Cost Savings - SSC has completed four acquisitions over the past 18 months, achieving significant cost savings, including a reduction in headcount by 45% and payroll costs by 44%, amounting to $7.8 million annually [6][8]. - The integration of these acquisitions is substantially complete as of December 2025, contributing to operational efficiencies [6]. Financial Projections - The company’s financial projections indicate a corporate growth of 49% to 82% in gross revenue and a growth of 155% to 345% in adjusted EBITDA post-retrofit [5][6]. - The annualized adjusted EBITDA per share is projected to increase from $0.09 to $0.16 depending on the case scenario [5].

Quick Read AdvisorShares Pure US Cannabis ETF (MSOS) dropped 26% to $4.80 by mid-January despite Trump’s December executive order. MSOS holds $921M and gains exposure to Curaleaf and Trulieve through swap contracts and direct equity positions. Curaleaf and Trulieve face 280E tax penalties and banking restrictions while cannabis remains a Schedule I substance. A recent study identified one single habit that doubled Americans’ retirement savings and moved retirement from dream, to reality. Read more ...

An updated edition of the Sept. 26, 2025, article.The sin stock market refers to a segment of the equity market made up of companies whose core businesses are often considered unethical, controversial or socially undesirable by parts of society. These typically include firms involved in alcohol, tobacco, gambling, weapons and cannabis. Despite moral objections, sin stocks remain a well-defined and actively traded investment category.From an investment standpoint, sin stocks function like any other equities, ...

Core Viewpoint - Rubicon Organics Inc. is a leading premium licensed producer of organic cannabis in Canada, announcing the grant of 1,002,773 restricted share units (RSUs) and 1,002,773 performance share units (PSUs) to its executives and employees [1] RSU Grant - The company has awarded a total of 1,002,773 RSUs under its Omnibus Equity Incentive Plan, which will vest over one to three years from the grant date, allowing holders to receive one common share or cash at the Board's discretion [2] PSU Grant - A total of 1,002,773 PSUs have been granted, which will vest after three years based on the achievement of specific performance targets, with each vested PSU entitling the holder to one common share or cash at the Board's discretion [3] Company Overview - Rubicon Organics is recognized as the Canadian leader in certified organic and premium cannabis, operating a vertically integrated model with a strong national distribution network [4] - The company's production capabilities are anchored by its Pacifica facility in Delta, BC, and the newly acquired Cascadia facility in Hope, BC, which will increase production capacity by over 40% [5] Market Position and Growth Potential - As the Canadian cannabis market rationalizes and global demand for high-quality cannabis rises, Rubicon Organics distinguishes itself through disciplined execution, brand equity, and consumer loyalty [6] - The company's focus on premium quality, innovation, and operational execution has led to consistent revenue growth and positive Adjusted EBITDA, positioning it for long-term growth potential [6]

Amendment adds incremental $25,000,000 and extends maturity date from September 29, 2028 to February 28, 2029 CHICAGO, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced an amendment to its existing $75,000,000 revolving credit facility agented by Chicago Atlantic Admin, LLC, initially entered into on September 30, 2025. The revolving credit facility commitment was increased from $75,000,0 ...

420 Investor launched in 2013, just ahead of Colorado legalizing for adult-use. We have moved the service to Seeking Alpha. Historically, we have provided great coverage of the sector with model portfolios, videos and written material to help investors learn about cannabis stocks, and we are excited to be doing it here!I reiterated my Strong Buy on Innovative Industrial Properties, Inc. ( IIPR ) in December, and it is slightly lower now, but I am downgrading it to Hold. I continue to view it as aAlan Brochs ...